Alibaba
BABA
Apple
AAPL
Intel
INTC
4
Netflix
NFLX
5
Tesla
TSLA
US Stock MarketDetailed Quotes
ICU SeaStar Medical
- 2.2000
- -0.2300-9.47%
Close Mar 27 16:00 ET
- 1.8000
- -0.4000-18.18%
Post 19:59 ET
19.18MMarket Cap-0.22P/E (TTM)
2.5100High2.1800Low389.01KVolume2.4300Open2.4300Pre Close832.90KTurnover4.50%Turnover RatioLossP/E (Static)8.72MShares20.695052wk High-9.36P/B19.01MFloat Cap1.500052wk Low--Dividend TTM8.64MShs Float550.0000Historical High--Div YieldTTM13.58%Amplitude1.5000Historical Low2.1410Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
SeaStar Medical Stock Forum
SeaStar Medical Achieves Key Milestones: FDA-Approved Therapy Generates Initial Sales
Net revenue for the year ended December 31, 2024, was $0.1 million, compared to no net revenue for the year ended December 31, 2023. The increase in net revenue is due to the initiation of sales of the QUELIMMUNE therapy in the third quarter of 2024, subsequent to its approval in the first quarter by the FDA to commercially sell the QUELIMMUNE pediatric...
No comment yet